Crux Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Sell
1,505
-63
-4% -$14.7K 0.13% 138
2026
Q1
$383K Buy
1,568
+1
+0.1% +$233 0.15% 129
2025
Q4
$324K Sell
1,567
-201
-11% -$39.7K 0.12% 139
2025
Q3
$328K Sell
1,768
-178
-9% -$30.5K 0.13% 137
2025
Q2
$297K Sell
1,946
-2,296
-54% -$353K 0.13% 140
2025
Q1
$704K Sell
4,242
-1,390
-25% -$217K 0.37% 85
2024
Q4
$815K Buy
+5,632
New +$873K 0.45% 68

Other funds holding JNJ

Crux Wealth Advisors's JNJ Position: Q2 2026 in Review

Crux Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 4% in Q2 2026, selling an estimated $14.7K and leaving 1,505 shares worth $382K. The position accounts for 0.13% of the portfolio, ranked #138.

Crux Wealth Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $815K in Q4 2024. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Crux Wealth Advisors held 1,505 shares of Johnson & Johnson worth $382K as of Q2 2026.
  • Crux Wealth Advisors sold 63 Johnson & Johnson shares in Q2 2026, an estimated $14.7K.
  • Johnson & Johnson made up 0.13% of Crux Wealth Advisors's portfolio in Q2 2026, its #138 holding.
  • Crux Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Crux Wealth Advisors's Johnson & Johnson position peaked at $815K in Q4 2024.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Crux Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.